Deputy Attorney General Todd Blanche outlined the initiative in a memo sent in May, according to the Wall Street Journal.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Synopsys to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 29, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or …

DUK's regulated utility model helps it recover costs and earn stable returns on clean energy investments.

Ventas, Inc. has surged 23% since July, recently hitting new 52-week highs and consolidating above its 30-week EMA. Despite overvaluation by fundamental metrics, VTR exhibits strong technical momentum, bullish volume, and institutional accumulation. Short- and long-term momentum readings are bullish, with the PPO indicator at 5.350 and volume supporting continued strength.

AMD (NASDAQ:AMD) had a pretty solid 2025. The stock gained close to 80% through the year amid optimism about the company's AI business with compelling product launches and notable contract wins.

The gold market initially tried to rally during the trading session here on Monday, but has given back any positive momentum and just simply fallen.

LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 30, 2025.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Philadelphia, Pennsylvania--(Newsfile Corp. - December 29, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) ("Fiserv" or the "Company") has been filed on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Fiserv securities during the Class Period may, no later than January 5, 2026, seek to be appointed as a lead plaintiff representative of the class.

Comcast (CMCSA) stock could be a wise investment at this time. Why? Because it offers high margins – indicative of its pricing power and ability to generate cash – at a discounted price.

Our multi-factor analysis indicates that it might be the right moment to buy additional shares of AVGO stock. The company's AI semiconductor business is scaling rapidly, with major customers such as Google, Meta, and OpenAI placing orders for custom XPUs across both training and inference workloads, driving an AI backlog of roughly $73 billion.

Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd. (“Hunan Saitumofei”) has entered into a one-year exclusive distribution agreement (the “Agreement”) with Shanghai Benke Medical Technology Co., Ltd. (“Shanghai Benke”) to promote and distribute its newly launched AI-Automated Blood Cell Morphology Analyzer (CM-B600) (the “Analyzer”) in East China throughout 2026. The collaboration is expected …

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 29, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" …

The biggest winners in your portfolio continue to be the oldest investments in existence. Gold and silver seemingly can't be stopped, with the former up more than 70% year-to-date (YTD) and the latter posting a staggering gain of over 150% YTD.

Lululemon Athletica Inc (NASDAQ:LULU) is facing a renewed proxy challenge from its founder and second-largest shareholder, Chip Wilson, as the apparel maker navigates a leadership transition and signs of slowing momentum. According to a Wall Street Journal report, Wilson formally launched a proxy fight seeking changes to Lululemon's board of directors, days after the company announced that CEO Calvin McDonald would step down in January 2026.

Landstar System, Inc. remains resilient and profitable, with its well-diversified service offerings and enhanced efficiency. Its asset-light business model reduces its exposure to macroeconomic headwinds and driver shortage risks. LTL undercapacity and robust fundamentals allow it to sustain its operations and dividends, while capitalizing on potential opportunities.

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Capital gets a lot of attention in small-cap markets. Control gets far less, even though it is usually the deciding factor between companies that execute and companies that react.

LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 5, 2024, and October 28, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 29, 2025.

UnitedHealth, a managed healthcare firm that provides health insurance, pharmacy benefit management, and care delivery to millions of clients, is now a $297 billion (by market cap) healthcare behemoth. UNH ended last fiscal year with more than $75 billion in cash, cash equivalents, available-for-sale debt securities, and equity securities balances. The company increased its dividend for 16 consecutive years, with a 10-year dividend growth rate of 19.3%.

Last week looked like a strong start for a Santa Claus rally